Haya: The Saudi Journal of Life Sciences (SJLS)
Volume-3 | Issue-02 | 144-147
Original Research Article
Assessment of In-Vitro Anti-Arthritic Potential of Methanolic Leaf Extract of Ricinus communis
Abdul Mukit Barbhuiya, M. Ramya Sri, Ch. Goutami, R. Sai Sindhu
Published : Feb. 28, 2018
Abstract
The use of plants for the treatment of various diseases was recorded in the
history. Many conventional medicines originate from plant sources: many decades
ago, most of the few effective drugs were plant-based. Examples include quinine
(from cinchona bark), digoxin (from foxglove), morphine (from the opium poppy)
and aspirin (from willow bark). The discovery and development of new drugs from
plant sources continues, with drug companies engaged in large-scale pharmacologic
screening of herbs. Arthritis is a condition typically characterized by pain, aching,
stiffness and swelling in and around one or more joints. Rheumatoid arthritis (RA) is
a disorder in which the body's own immune system starts to attack body tissues.
Ricinus communis, the castorbean or castor-oil-plant is a species of flowering plant in
the spurge family, Euphorbiaceae. Many authors have reported that the plant has
promised Antioxidant activity, Antinociceptive activity, Antiulcer activity,
Antiasthmatic activity, Anti-fertility activity, Antihistaminic Activity etc cited in
literature review. The present study is aimed to evaluate the methanolic leaf extract of
Ricinus communis for acclaimed anti-arthritic activity by using protein denaturation
method. Diclofenac sodium is used as a standard drug. From the results of the present
study it can be stated that the methanolic leaf extract of Ricinus communis at two
different concentrations (250mcg/ml & 500mcg/ml) is capable of inhibiting the
denaturation of protein in rheumatic disease.